
==== Front
Oncol Res
Oncol Res
OR
Oncology Research
0965-0407
1555-3906
Tech Science Press USA

56894
10.32604/or.2024.056894
Retraction
Retraction: Long noncoding RNA CAMTA1 promotes proliferation and mobility of the human breast cancer cell line MDA-MB-231 via targeting miR-20b
Retraction: Long Noncoding RNA CAMTA1 Promotes Proliferation and Mobility of the Human Breast Cancer Cell Line MDA-MB-231 via Targeting miR-20b
Retraction: Long Noncoding RNA CAMTA1 Promotes Proliferation and Mobility of the Human Breast Cancer Cell Line MDA-MB-231 via Targeting miR-20b
Oncology Research Editorial Office
2024
18 9 2024
18 9 2024
32 10 16791680
© 2024 The Author.
2024
Published by Tech Science Press.
https://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
==== Body
pmcThe published article titled “Long noncoding RNA CAMTA1 promotes proliferation and mobility of the human breast cancer cell line MDA-MB-231 via targeting miR-20b” has been retracted from Oncology Research, Vol. 26, No. 4, 2018, pp. 625–635.

DOI: 10.3727/096504017X14953948675395

URL: https://www.techscience.com/or/v26n4/56675

Following the publication, concerns have been raised about a number of figures in this article. The western blots in this article were presented with atypical, unusually shaped and possibly anomalous protein bands in many cases.

The authors were contacted and invited to comment on the concerns raised and to provide the original, unmodified figures, but did not respond. The Editors-in-Chief therefore no longer have confidence in the integrity of the data in this article and decided to retract this article.

All authors have not responded to correspondence about this retraction. As a responsible publisher, we hold the reliability and integrity of our published content in high regard. We deeply regret any inconvenience caused by this situation to our readers and all concerned parties.
